Butterfly Network

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Butterfly Network reports Q4 growth, seeks CEO for tech scaling

Butterfly Network's Q4 2022 performance showed revenue growth and improved cost management.
The company's strengths lie in democratizing healthcare, international expansion, and cost efficiency.
Challenges include external factors affecting deployments and the ongoing CEO search.
Opportunities for growth include revenue expectations, product developments, and efficiency enhancements.

Butterfly Network reports stable Q1 revenue, eyes AI and home markets

Butterfly Network's Q1 2023 performance showed mixed results with flat revenue but improved margins and reduced EBITDA loss.
The company's strengths in democratizing medical imaging, AI utilization, and strong cash position position it well for future growth.
Challenges include product revenue decline, slower customer growth, and the need to address international distribution weaknesses.
Opportunities in AI, software expansion, home market penetration, and exciting developments offer avenues for future success.

Butterfly Network reports Q2 revenue, focuses on innovation and growth

Butterfly Network's Q2 2023 performance showed mixed results with growth in U.S. sales but a decline in international sales.
The company is leveraging core strengths, launching innovative products, and focusing on revenue growth initiatives.
Challenges include declining international sales and potential impact on current sales due to the upcoming iQ3 launch.
Opportunities lie in new product launches, e-commerce strategy, market expansion, and technology advancements beyond iQ3.

Butterfly Network reports Q3 revenue decline but eyes future growth

Butterfly Network's Q3 2023 performance reflects a strategic shift towards higher-margin offerings and improved operational efficiency.
The company's strengths in revolutionizing ultrasound imaging, education offerings, and partnerships position it for future growth.
Challenges include revenue decline, competitive landscape, and the need for sustained investment in R&D and operational improvements.
Opportunities in upcoming product launches, market expansion, and revenue-sharing agreements present avenues for growth and innovation.

Butterfly Network reports improved Q4 financials and plans expansion

Butterfly Network's financials improved in Q4 2023 with revenue decline but better margins.
Strategic focus on product innovation, global expansion, and revenue growth drivers.
Challenges include revenue decline, EBITDA loss, and potential regulatory impacts.
Opportunities lie in planned growth strategies, resource additions, and lobbying efforts.

Butterfly Network excels in Q1 2024, eyes global expansion

Butterfly Network's Q1 2024 showcased strong revenue growth and operational improvements.
While facing challenges with compliance and financial losses, the company is optimistic about growth.
Strategic priorities and innovative technologies position Butterfly for future success and market expansion.

Butterfly Network reports robust Q2 growth, eyes AI opportunities

Butterfly Network's Q2 performance reflects strong revenue growth, improved cost efficiency, and a positive outlook for the year. The company's strengths in sustainable revenue growth, AI advancements, and strategic partnerships enhance its competitive position. Challenges in regulatory compliance and market expansion require careful navigation, while opportunities in AI, partnerships, and clinical applications offer avenues for growth.

Butterfly Network posts robust Q3 results, eyes tech innovation for growth

Butterfly Network's Q3 2024 performance reflects strong revenue growth, improved profitability, and strategic initiatives for future expansion and innovation.
While facing challenges in managing EBITDA losses and regulatory compliance, the company's financial strength and growth outlook present a positive trajectory.
Opportunities in technological innovation, market expansion, and healthcare initiatives position Butterfly Network for sustained growth and competitive advantage in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at the Goldman Sachs 45th Annual Global Healthcare Conference. The presentation will take place on Wednesday, June 12, 2024, at 10:00 am ET in Miami, Florida. A l.

Butterfly Network to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today introduced its first specialty product, iQ+ Bladder™, now available for purchase in the United States. The bundled solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with p.

Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, iQ+ Bladder, in the United States

Definitive Healthcare Corp

Enovis Corp

Hims & Hers Health

Pulmonx

We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.

5 Medical Info Systems Stocks to Buy for Stable Returns

Butterfly Network, Inc. (NYSE:BFLY ) Q1 2024 Earnings Conference Call May 1, 2024 5:00 PM ET Company Participants Heather Getz - Chief Financial and Operations Officer Joe DeVivo - Chairman and CEO Conference Call Participants Suraj Kalia - Oppenheimer & Co. Josh Jennings - TD Cowen Operator Good afternoon. Thank you for attending the Butterfly Network First Quarter 2024 Earnings Call.

Butterfly Network, Inc. (BFLY) Q1 2024 Earnings Call Transcript

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. Joseph DeVivo, Butterfly's Chairman and CEO said, “We achieved our strongest first quarter in Butterfly's history with all channels contributing. Our business returned t.

Butterfly Network Reports First Quarter 2024 Financial Results

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on May 1, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 5:00.

Butterfly Network to Report First Quarter 2024 Financial Results on May 1, 2024

BURLINGTON, Mass. & GQERBERHA, South Africa--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced a tripartite collaboration with implementing partner Clinton Health Access Initiative (CHAI) (a global health organization committed to saving lives, reducing the burden of disease and strengthening health systems), and training partner Global Ultra.

Butterfly Network, Clinton Health Access Initiative, and Global Ultrasound Institute Partner to Advance Maternal and Fetal Health in South Africa

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #EUMDR--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the attainment of its European Union Medical Device Regulation (EU MDR) certificate for the Butterfly iQ+ ultrasound system. This additional certification allows Butterfly to release important new features to all existing and pro.

Butterfly Network Obtains EU MDR Certification for Butterfly iQ+ Devices in Key European Markets

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, hosted its first investor day under President, Chief Executive Officer and Chairman, Joseph DeVivo. The event featured presentations from members of Butterfly's executive and senior leadership team, providing insights into the Company's product, software and services portfolio within its core poi.

Butterfly Network Announces Successful Investor Day

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, will host its previously announced Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange. A live audio webcast of the event will be available beginning at approximately 12:00pm ET, and will be available on Butterfly's Events & Presentations page on the.

Butterfly Network Announces Investor Day

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech &amp.

Butterfly Network to Participate at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Here is how Butterfly Network, Inc. (BFLY) and BellRing Brands (BRBR) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Butterfly Network (BFLY) This Year?

Butterfly Network, Inc. (BFLY) Q4 2023 Earnings Call Transcript

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.17 per share a year ago.

Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), an innovative digital health company transforming care through a unique combination of portable, semiconductor-based ultrasound technology, intuitive software, services and educational offerings that can make medical imaging more accessible than ever before, today announced financial results for the quarter and year ended December 31, 2023, and provided a business update. Joseph D.

Butterfly Network Reports Fourth Quarter 2023 Financial Results

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 44th Annual Health Care Conference in Boston on March 5, 2024. Joseph DeVivo, President, Chief Executive Officer & Chairman, and Heather Getz, Executive Vice President & Chief Financial and Operatio.

Butterfly Network to Participate at the TD Cowen 44th Annual Health Care Conference on March 5, 2024

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will host an Investor Day on Monday March 18, 2024, beginning at 12:00pm ET at the New York Stock Exchange. During the event, Butterfly's executive management team will present the Company's product, software and services portfolio within the point-of-care ultrasound landscape, as well as its s.

Butterfly Network to Host Investor Day on Monday, March 18, 2024, at the New York Stock Exchange

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will report fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host.

Butterfly Network, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #ButterflyiQ3--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced today the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3™, which received FDA clearance last month. Butterfly iQ3 is powered by the Company's most advanced semiconductor chip w.

Butterfly Network Launches Next-Generation Butterfly iQ3™ in the United States

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, provided a business update today at the 42nd Annual J.P. Morgan Healthcare Conference. A webcast replay of the conference presentation can be viewed here, and will be available until February 10th, 2024. The presentation slide deck with animated videos can be.

Butterfly Network Provides Business Update During 42nd Annual J.P. Morgan Healthcare Conference Presentation

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #ButterflyiQ--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3. The new device is the company's third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system. Butte.

Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. To schedule a one-on-one meeting with Joseph DeVivo, Chief Executive Officer, and Heather Getz, Chief Financial and Operations Officer, please reach out to your Needham.

Butterfly to Participate at the 26th Annual Needham Growth Conference

BURLINGTON, Mass. & SAN MATEO, Calif.--(BUSINESS WIRE)---- $BFLY #ButterflyiQ--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Mendaera, a Silicon Valley-based company developing technology to help healthcare providers more easily and confidently perform procedures through the power of medical robotics, today announced an agreement to commercialize a novel robotic system.

Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-11, 2024, in San Francisco, California. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will prese.

News for Butterfly Network Stock (BFLY)